270 related articles for article (PubMed ID: 11713237)
1. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
Parikka V; Lehenkari P; Sassi ML; Halleen J; Risteli J; Härkönen P; Väänänen HK
Endocrinology; 2001 Dec; 142(12):5371-8. PubMed ID: 11713237
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
3. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
Shorey S; Heersche JN; Manolson MF
Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
[TBL] [Abstract][Full Text] [Related]
7. Regulation and enzymatic basis of bone resorption by human osteoclasts.
Fuller K; Kirstein B; Chambers TJ
Clin Sci (Lond); 2007 Jun; 112(11):567-75. PubMed ID: 17241109
[TBL] [Abstract][Full Text] [Related]
8. Matrix collagen of devitalized bone is resistant to osteoclastic bone resorption.
Shimizu H; Sakamoto S; Sakamoto M
Connect Tissue Res; 1989; 20(1-4):169-75. PubMed ID: 2612150
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
Wilson SR; Peters C; Saftig P; Brömme D
J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
[TBL] [Abstract][Full Text] [Related]
10. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
12. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
[TBL] [Abstract][Full Text] [Related]
14. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
Sato T; Foged NT; Delaissé JM
J Bone Miner Res; 1998 Jan; 13(1):59-66. PubMed ID: 9443791
[TBL] [Abstract][Full Text] [Related]
15. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.
Everts V; Delaissé JM; Korper W; Niehof A; Vaes G; Beertsen W
J Cell Physiol; 1992 Feb; 150(2):221-31. PubMed ID: 1734028
[TBL] [Abstract][Full Text] [Related]
16. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone.
Everts V; Delaissé JM; Korper W; Beertsen W
J Bone Miner Res; 1998 Sep; 13(9):1420-30. PubMed ID: 9738514
[TBL] [Abstract][Full Text] [Related]
17. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone.
Everts V; Korper W; Jansen DC; Steinfort J; Lammerse I; Heera S; Docherty AJ; Beertsen W
FASEB J; 1999 Jul; 13(10):1219-30. PubMed ID: 10385612
[TBL] [Abstract][Full Text] [Related]
18. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
Garnero P; Ferreras M; Karsdal MA; Nicamhlaoibh R; Risteli J; Borel O; Qvist P; Delmas PD; Foged NT; Delaissé JM
J Bone Miner Res; 2003 May; 18(5):859-67. PubMed ID: 12733725
[TBL] [Abstract][Full Text] [Related]
19. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
20. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Vääräniemi J; Halleen JM; Kaarlonen K; Ylipahkala H; Alatalo SL; Andersson G; Kaija H; Vihko P; Väänänen HK
J Bone Miner Res; 2004 Sep; 19(9):1432-40. PubMed ID: 15312243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
